NeuronesAct. Aktie
46,80EUR | -0,05EUR | -0,11% |
WKN: 938282 / ISIN: FR0004050250
Personal
2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Personal am Ende des Jahres | 5 372 | 5 589 | 5 869 | 6 406 | 6 749 |
Umsatz pro Mitarbeiter in Mio. EUR | 0,09 | 0,09 | 0,10 | 0,10 | 0,11 |
Bilanz (in Mio. EUR) - Aktiva
2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Summe Umlaufvermögen | 413 | 449 | 464 | 507 | 546 |
Summe Anlagevermögen | 97 | 101 | 104 | 111 | 128 |
Summe Aktiva | 510 | 550 | 568 | 617 | 674 |
Bilanz (in Mio. EUR) - Passiva
2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Summe Fremdkapital | 183 | 191 | 215 | 241 | 266 |
Summe Eigenkapital | 327 | 359 | 353 | 376 | 408 |
Summe Passiva | 510 | 550 | 568 | 617 | 674 |
Adresse
Immeuble Le Clemenceau 1, 92000 Nanterre | |
Telefon | +33 (1) 41-37-41-37 |
Fax | +33 (1) 47-24-40-46 |
Internet | http://www.neurones.net |
Management
Bertrand Ducurtil
Chief Operating Officer & Director |
Daphné de Chammard
Director |
Emmanuelle Canza
Director |
Hervé Pichard
Director |
Jean-Louis Pacquement
Independent Director |
Luc de Chammard
Chairman & Chief Executive Officer |
Marie-Françoise Jaubert
Independent Director |
Matthieu Vautier
Director-Marketing & Communication |
Paul-César Bonnel
Director-Finance & Administrative |